Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
82.15
+4.46 (5.74%)
At close: Mar 6, 2026

SHA:688266 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
21,74624,53816,49414,01410,00814,112
Market Cap Growth
26.60%48.77%17.70%40.02%-29.08%-9.11%
Enterprise Value
20,78523,57815,21312,6589,44313,028
Last Close Price
82.1592.7062.3152.9441.7058.80
Forward PE
93.1835.5135.5135.5135.51-
PS Ratio
26.7630.1930.9536.2633.1174.13
PB Ratio
18.9321.3613.178.5212.7111.26
P/TBV Ratio
19.5322.0413.708.9614.9813.07
P/OCF Ratio
--431.73---
EV/Sales Ratio
25.5729.0128.5432.7631.2468.44
Debt / Equity Ratio
0.980.980.830.540.700.18
Net Debt / Equity Ratio
-0.84-0.84-0.92-0.83-0.63-0.78
Net Debt / EBITDA Ratio
7.827.826.633.821.032.11
Net Debt / FCF Ratio
--20.094.601.091.86
Asset Turnover
--0.180.170.180.10
Inventory Turnover
--0.260.300.370.19
Quick Ratio
--1.712.081.573.35
Current Ratio
--1.882.221.773.69
Return on Equity (ROE)
-13.38%-13.38%-10.37%-24.27%-47.59%-31.38%
Return on Assets (ROA)
---4.60%-10.91%-19.70%-17.02%
Return on Capital Employed (ROCE)
---13.30%-22.70%-57.30%-37.10%
Earnings Yield
-0.74%-0.66%-0.84%-1.99%-4.57%-3.20%
FCF Yield
---0.35%-2.11%-4.59%-3.72%
Buyback Yield / Dilution
0.61%0.61%-3.71%-6.74%0.19%-2.20%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.